A Year of (Bio)chemical Elements

For March, it’s a renal three-fer: sodium, potassium and chlorine

Quira Zeidan
March 1, 2019

Every month in 2019 we are looking at one or more chemical elements essential for life in commemoration of the 150th anniversary of Mendeleev’s periodic table. For January and February, we selected hydrogen and iron, respectively, and described their function in biochemical reactions involving electron transport.

Sodium-Potassium-Chlorine The Na+/K+ pump uses energy from the breakdown of adenosine triphosphate into adenosine diphosphate and inorganic phosphate to move 3 Na ions out to the extracellular space and 2 K ions into the cytoplasm, creating a charge imbalance across the cellular membrane. CNX OpenStax/Wikimedia Commons

March is National Kidney Month, so we are highlighting three elements central to renal function: sodium, or Na; potassium, or K; and chlorine, or Cl.

Sodium and potassium, atomic numbers 11 and 19, respectively, are highly reactive metals with similar chemical properties, both listed in group 1, the alkali metals, of the periodic table. Both have a single valence electron in their outer shell, which they readily donate, creating positive ions, or Na+ and K+ cations. Chlorine, a gas at room temperature with atomic number 17, is a highly reactive element with an affinity for electrons. As a strong oxidizing agent, chlorine is abundant as chloride anions, or Cl-, that combine with Na+, K+ and other cations to form chloride salts.

Sodium is the seventh most abundant element on Earth, and potassium is the 17th. They exist in rock-forming minerals such as salt and granite. Chlorine is the 21st most abundant element in the Earth’s crust, occurring exclusively as ionic chloride compounds. Sodium and chlorine, constantly leached by water from mineral salts, are the most abundant elements dissolved in the oceans.

Sodium and potassium ions are crucial for most cells. Microorganisms use transmembrane ion pumps, such as the Na+/H+ antiporter or Na+ translocation systems coupled to metabolic reactions, to move Na+ ions against their concentration gradient, generating electrochemical energy to drive solute transport or to move flagellar motors (in bacteria) and to produce reducing power for biochemical reactions. K+ is the main monovalent cation in prokaryotes; it is essential to maintain intracellular pH, to generate energy via electrochemical gradients and to sustain turgor pressure.

In animals, the Na+/K+ ion pump pushes sodium and potassium across the cell membrane in opposite directions, maintaining a low Na+ concentration and a high K+ concentration inside the cell. This ionic imbalance between the cytosol and the extracellular medium creates a transmembrane potential — or voltage difference — essential to conducting electrical signals in excitable neurons and myocytes. A similar ion transporter moves H+ and K+ ions across the membrane of parietal cells, helping mammals acidify stomach contents and digest food.

Chloride ions are also necessary for all known life. Some prokaryotes use chloride compounds as a carbon and energy source and chlorine ions as terminal electron acceptors during anaerobic growth. In most cells at rest, the concentration of Cl- is lower in the cytosol than in the extracellular fluid via activity of gated ion channels that contribute to the polarization of cellular membranes. In animals, parietal cells in the stomach secrete Cl- ions to produce hydrochloric acid required for food breakdown. In humans, the defective protein in the disease cystic fibrosis is an ion channel specific for Cl- whose impaired activity results in less bactericidal activity — and more infections — in the lungs.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Quira Zeidan

Quira Zeidan is the ASBMB’s education and public outreach coordinator.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Mass spec method captures proteins in native membranes
Journal News

Mass spec method captures proteins in native membranes

Nov. 25, 2025

Yale scientists developed a mass spec protocol that keeps proteins in their native environment, detects intact protein complexes and tracks drug binding, offering a clearer view of membrane biology.

Laser-assisted cryoEM method preserves protein structure
Journal News

Laser-assisted cryoEM method preserves protein structure

Nov. 25, 2025

University of Wisconsin–Madison researchers devised a method that prevents protein compaction during cryoEM prep, restoring natural structure for mass spec studies. The approach could expand high-resolution imaging to more complex protein systems.

Method sharpens proteome-wide view of structural changes
Journal News

Method sharpens proteome-wide view of structural changes

Nov. 25, 2025

Researchers developed a method that improves limited proteolysis coupled with mass spectrometry, separating true changes from abundance or splicing effects.

Discoveries made possible by DNA
Feature

Discoveries made possible by DNA

Nov. 24, 2025

The discovery of DNA’s double helix revealed how genetic information is stored, copied and expressed. Revisit that breakthrough and traces how it laid the foundation for modern molecular biology, genomics and biotechnology.

Unraveling the language of histones
Profile

Unraveling the language of histones

Nov. 20, 2025

Philip Cole presented his research on how posttranslational modifications to histones are involved in gene expression and how these modifications could be therapeutically targeted to treat diseases like cancer.

How Alixorexton could transform narcolepsy treatment
News

How Alixorexton could transform narcolepsy treatment

Nov. 18, 2025

A new investigational drug, alixorexton, targets the brain’s orexin system to restore wakefulness in people with narcolepsy type 1. Alkermes chemist Brian Raymer shares how molecular modeling turned a lab idea into a promising phase 3 therapy.